Literature DB >> 12200364

X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction.

Channing Yu1, Kathy K Niakan, Mark Matsushita, George Stamatoyannopoulos, Stuart H Orkin, Wendy H Raskind.   

Abstract

Transcription factor GATA-1 is essential for the development of erythroid cells and megakaryocytes. Each of its 2 zinc fingers is critical for normal function. The C-terminal finger is necessary for DNA binding. The N finger mediates interaction with FOG-1, a cofactor for GATA-1, and also modulates DNA-binding affinity, notably at complex or palindromic GATA sites. Residues of the N finger-mediating interaction with FOG-1 lie on the surface of the N finger facing away from DNA. Strong sequence conservation of residues facing DNA suggests that this other surface may also have an important role. We report here that a syndrome of X-linked thrombocytopenia with thalassemia in humans is caused by a missense mutation (Arg216Gln) in the GATA-1 N finger. To investigate the functional consequences of this substitution, we used site-directed mutagenesis to alter the corresponding residue in GATA-1. Compared with wild-type GATA-1, Arg216Gln GATA-1 shows comparable affinity to single GATA sites but decreased affinity to palindromic sites. Arg216Gln GATA-1 interacts with FOG-1 similarly with wild-type GATA-1. Arg216Gln GATA-1 supports erythroid maturation of GATA-1 erythroid cells, albeit at reduced efficiency compared with wild-type GATA-1. Together, these findings suggest that residues of the N finger of GATA-1-facing DNA contribute to GATA-1 function apart from interaction with the cofactor FOG-1. This is also the first example of beta-thalassemia in humans caused by a mutation in an erythroid transcription factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200364      PMCID: PMC2808424          DOI: 10.1182/blood-2002-02-0387

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.

Authors:  Y Fujiwara; C P Browne; K Cunniff; S C Goff; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction.

Authors:  C D Trainor; J G Omichinski; T L Vandergon; A M Gronenborn; G M Clore; G Felsenfeld
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line.

Authors:  M J Weiss; C Yu; S H Orkin
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Consequences of GATA-1 deficiency in megakaryocytes and platelets.

Authors:  P Vyas; K Ault; C W Jackson; S H Orkin; R A Shivdasani
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

Review 5.  GATA transcription factors: key regulators of hematopoiesis.

Authors:  M J Weiss; S H Orkin
Journal:  Exp Hematol       Date:  1995-02       Impact factor: 3.084

6.  A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.

Authors:  R A Shivdasani; Y Fujiwara; M A McDevitt; S H Orkin
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

7.  FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.

Authors:  A P Tsang; J E Visvader; C A Turner; Y Fujiwara; C Yu; M J Weiss; M Crossley; S H Orkin
Journal:  Cell       Date:  1997-07-11       Impact factor: 41.582

Review 8.  Embryonic stem cells and transgenic mice in the study of hematopoiesis.

Authors:  S H Orkin
Journal:  Int J Dev Biol       Date:  1998       Impact factor: 2.203

9.  Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.

Authors:  C Labbaye; M Valtieri; T Barberi; E Meccia; B Masella; E Pelosi; G L Condorelli; U Testa; C Peschle
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.

Authors:  D Orlic; S Anderson; L G Biesecker; B P Sorrentino; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more
  52 in total

Review 1.  GATA transcription factors in hematologic disease.

Authors:  Alan B Cantor
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

2.  Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.

Authors:  Belinda Giardine; Joseph Borg; Douglas R Higgs; Kenneth R Peterson; Sjaak Philipsen; Donna Maglott; Belinda K Singleton; David J Anstee; A Nazli Basak; Barnaby Clark; Flavia C Costa; Paula Faustino; Halyna Fedosyuk; Alex E Felice; Alain Francina; Renzo Galanello; Monica V E Gallivan; Marianthi Georgitsi; Richard J Gibbons; Piero C Giordano; Cornelis L Harteveld; James D Hoyer; Martin Jarvis; Philippe Joly; Emmanuel Kanavakis; Panagoula Kollia; Stephan Menzel; Webb Miller; Kamran Moradkhani; John Old; Adamantia Papachatzopoulou; Manoussos N Papadakis; Petros Papadopoulos; Sonja Pavlovic; Lucia Perseu; Milena Radmilovic; Cathy Riemer; Stefania Satta; Iris Schrijver; Maja Stojiljkovic; Swee Lay Thein; Jan Traeger-Synodinos; Ray Tully; Takahito Wada; John S Waye; Claudia Wiemann; Branka Zukic; David H K Chui; Henri Wajcman; Ross C Hardison; George P Patrinos
Journal:  Nat Genet       Date:  2011-03-20       Impact factor: 38.330

3.  GATA1 function, a paradigm for transcription factors in hematopoiesis.

Authors:  Rita Ferreira; Kinuko Ohneda; Masayuki Yamamoto; Sjaak Philipsen
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 4.  Megakaryocyte biology and related disorders.

Authors:  Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

Review 6.  Thrombocytopenias: a clinical point of view.

Authors:  Dino Veneri; Massimo Franchini; Federica Randon; Ilaria Nichele; Giovanni Pizzolo; Achille Ambrosetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

7.  Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA.

Authors:  Darren L Bates; Yongheng Chen; Grace Kim; Liang Guo; Lin Chen
Journal:  J Mol Biol       Date:  2008-07-02       Impact factor: 5.469

8.  Analysis of disease-causing GATA1 mutations in murine gene complementation systems.

Authors:  Amy E Campbell; Lorna Wilkinson-White; Joel P Mackay; Jacqueline M Matthews; Gerd A Blobel
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

9.  Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis.

Authors:  Ming Yu; Laura Riva; Huafeng Xie; Yocheved Schindler; Tyler B Moran; Yong Cheng; Duonan Yu; Ross Hardison; Mitchell J Weiss; Stuart H Orkin; Bradley E Bernstein; Ernest Fraenkel; Alan B Cantor
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

10.  Haem-regulated eIF2alpha kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency.

Authors:  Sijin Liu; Sanchita Bhattacharya; Anping Han; Rajasekhar N V S Suragani; Wanting Zhao; Rebecca C Fry; Jane-Jane Chen
Journal:  Br J Haematol       Date:  2008-07-28       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.